Barr Drops Suit Vs. FDA Over Allegra Marketing Exclusivity
Generic drug maker Barr Pharmaceuticals Inc. has dropped a lawsuit against the U.S. Food and Drug Administration over exclusive marketing rights to a generic version of Sanofi-Aventis' allergy treatment Allegra....To view the full article, register now.
Already a subscriber? Click here to view full article